Professional
Provider Research
Center

This Research Center is intended as a tool for licensed veterinarians when considering the addition of Pinnaclife® Animal Health Products to a patient care plan. Pinnaclife® Animal Health Products and this Research Center are not intended to diagnose, treat, cure, or prevent any disease.

Deterrent

For cases in which a deterrent is needed against biting and licking of the effected area, Pinnaclife® Deterrent Wound Shield and Deterrent Antipruritic Spray feature the bittering agent Denatonium Benzoate to make the treated area less palatable to the animal. Denatonium Benzoate is safe, effective, and is used worldwide as a deterrent against undesired human and animal mouth contact. Because it is so powerful, Denatonium Benzoate is effective in low doses and does not affect the healing properties of the formula. Please apply all deterrent products with a gloved hand to prevent the transfer of this bitter tasting deterrent to human skin.

Deterrent Atopic Dermatitis

DeBoer, D. J., & Hillier, a. (2001). The ACVD task force on canine atopic dermatitis (XV): fundamental concepts in clinical diagnosis. Veterinary immunology and immunopathology, 81(3-4), 271-6. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11553389 [Full Text]
Deboer, D. J., & Marsella, R. (2001). The ACVD task force on canine atopic dermatitis ( XII ): the relationship of cutaneous infections to the pathogenesis and clinical course of canine atopic dermatitis. Veterinary Immunology and Immunopathology, 81, 239-249. [Full Text]
Hillier, A., & Griffin, C. E. (2001). The ACVD task force on canine atopic dermatitis ( I ): incidence and prevalence. Veterinary Immunology and Immunopathology, 81, 147-151. [Full Text]
Marsella, R., & Sousa, C. A. (2001). The ACVD task force on canine atopic dermatitis (XIII): threshold phenomenon and summation of effects. Veterinary Immunology and Immunopathology, 81(3-4), 251-254. doi:10.1016/S0165-2427(01)00303-8 [Full Text]
Olivry, T., & Hill, P. B. (2001). The ACVD task force on canine atopic dermatitis (VIII): is the epidermal lipid barrier defective? Veterinary immunology and immunopathology, 81(3-4), 215-8. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11553382 [Full Text]